Panayiotis Louca
Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app
Louca, Panayiotis; Murray, Benjamin; Klaser, Kerstin; Graham, Mark S.; Mazidi, Mohsen; Leeming, Emily R.; Thompson, Ellen; Bowyer, Ruth; Drew, David A.; Nguyen, Long H.; Merino, Jordi; Gomez, Maria; Mompeo, Olatz; Costeira, Ricardo; Sudre, Carole H.; Gibson, Rachel; Steves, Claire J.; Wolf, Jonathan; Franks, Paul W.; Ourselin, Sebastien; Chan, Andrew T.; Berry, Sarah E.; Valdes, Ana M.; Calder, Philip C.; Spector, Tim D.; Menni, Cristina
Authors
Benjamin Murray
Kerstin Klaser
Mark S. Graham
Mohsen Mazidi
Emily R. Leeming
Ellen Thompson
Ruth Bowyer
David A. Drew
Long H. Nguyen
Jordi Merino
Maria Gomez
Olatz Mompeo
Ricardo Costeira
Carole H. Sudre
Rachel Gibson
Claire J. Steves
Jonathan Wolf
Paul W. Franks
Sebastien Ourselin
Andrew T. Chan
Sarah E. Berry
Professor ANA VALDES Ana.Valdes@nottingham.ac.uk
Professor of Molecular & Genetic Epidemiology
Philip C. Calder
Tim D. Spector
Cristina Menni
Abstract
Objectives Dietary supplements may ameliorate SARS-CoV-2 infection, although scientific evidence to support such a role is lacking. We investigated whether users of the COVID-19 Symptom Study app who regularly took dietary supplements were less likely to test positive for SARS-CoV-2 infection.
Design App-based community survey.
Setting 445?850 subscribers of an app that was launched to enable self-reported information related to SARS-CoV-2 infection for use in the general population in the UK (n=372?720), the USA (n=45?757) and Sweden (n=27?373).
Main exposure Self-reported regular dietary supplement usage (constant use during previous 3 months) in the first waves of the pandemic up to 31 July 2020.
Main outcome measures SARS-CoV-2 infection confirmed by viral RNA reverse transcriptase PCR test or serology test before 31 July 2020.
Results In 372?720 UK participants (175?652 supplement users and 197?068 non-users), those taking probiotics, omega-3 fatty acids, multivitamins or vitamin D had a lower risk of SARS-CoV-2 infection by 14% (95% CI (8% to 19%)), 12% (95% CI (8% to 16%)), 13% (95% CI (10% to 16%)) and 9% (95% CI (6% to 12%)), respectively, after adjusting for potential confounders. No effect was observed for those taking vitamin C, zinc or garlic supplements. On stratification by sex, age and body mass index (BMI), the protective associations in individuals taking probiotics, omega-3 fatty acids, multivitamins and vitamin D were observed in females across all ages and BMI groups, but were not seen in men. The same overall pattern of association was observed in both the US and Swedish cohorts.
Conclusion In women, we observed a modest but significant association between use of probiotics, omega-3 fatty acid, multivitamin or vitamin D supplements and lower risk of testing positive for SARS-CoV-2. We found no clear benefits for men nor any effect of vitamin C, garlic or zinc. Randomised controlled trials are required to confirm these observational findings before any therapeutic recommendations can be made.
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 4, 2021 |
Online Publication Date | Apr 19, 2021 |
Publication Date | 2021-06 |
Deposit Date | May 9, 2021 |
Publicly Available Date | May 18, 2021 |
Journal | BMJ Nutrition, Prevention & Health |
Print ISSN | 2516-5542 |
Electronic ISSN | 2516-5542 |
Publisher | BMJ Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 4 |
Issue | 1 |
Article Number | e000250 |
DOI | https://doi.org/10.1136/bmjnph-2021-000250 |
Public URL | https://nottingham-repository.worktribe.com/output/5493608 |
Publisher URL | https://nutrition.bmj.com/content/4/1/149 |
Files
Modest effects of dietary supplements
(1.4 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search